An international assessment of ovarian cancer incidence and mortality

Gynecologic Oncology

Volumn 130, Issue 1, 2013, Pages 107-114

  Lowe, Kimberly A ^a   Chia, Victoria M ^b   Taylor, Aliki ^b   O'Malley, Cynthia ^b   Kelsh, Michael ^b   Mohamed, Muhima ^a   Mowat, Fionna S ^a   Goff, Barbara ^c  

^a EXPONENT INC   (United States)

^b AMGEN INC   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

GLOBOCAN; Incidence; Ovarian cancer; SEER; Survival

Indexed keywords

AGE; AGED; ARTICLE; ASIA; AUSTRIA; BELGIUM; CANADA; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER MORTALITY; CANCER SURVIVAL; CHINA; CLINICAL ASSESSMENT; EUROPE; FATALITY; FEMALE; HUMAN; INDIA; JAPAN; MAJOR CLINICAL STUDY; MEXICO; NETHERLANDS; OVARY CANCER; PACIFIC ISLANDS; PORTUGAL; PREVALENCE; PRIORITY JOURNAL; RUSSIAN FEDERATION; SWEDEN; UNITED KINGDOM; UNITED STATES; WESTERN HEMISPHERE;

AGE FACTORS; AGED; ASIA; CHINA; EUROPE; FEMALE; HUMANS; INCIDENCE; MIDDLE AGED; OCEANIA; OVARIAN NEOPLASMS; SEER PROGRAM; UNITED STATES;

EID: 84879079619     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2013.03.026     Document Type: Article

References (30)

1. A. Jemal, F. Bray, M.M. Center, J. Ferlay, E. Ward, and D. Forman Global cancer statistics CA Cancer J Clin 61 2 2011 69 90
2. GLOBOCAN 2008 v1.2 Cancer incidence and mortality worldwide: IARC CancerBase No. 10 [Internet] http://globocan.iarc.fr
3. A. Jemal, R. Siegel, J. Xu, and E. Ward Cancer statistics, 2010 CA Cancer J Clin 60 5 2010 277 300
4. C.H. Holschneider, and J.S. Berek Ovarian cancer: epidemiology, biology, and prognostic factors Semin Surg Oncol 19 1 2000 3 10
5. A. Klint, L. Tryggvadottir, F. Bray, M. Gislum, T. Hakulinen, and H.H. Storm Trends in the survival of patients diagnosed with cancer in female genital organs in the Nordic countries 1964-2003 followed up to the end of 2006 Acta Oncol 49 5 2010 632 643
6. World Population Prospects: The 2010 Revision.
7. C. La Vecchia Epidemiology of ovarian cancer: a summary review Eur J Cancer Prev 10 2 2001 125 129
8. F. Levi, F. Lucchini, E. Negri, P. Boyle, and C. La Vecchia Cancer mortality in Europe, 1990-1994, and an overview of trends from 1955 to 1994 Eur J Cancer 35 10 1999 1477 1516
9. D.M. Parkin, F. Bray, J. Ferlay, and P. Pisani Estimating the world cancer burden: Globocan 2000 Int J Cancer 94 2 2001 153 156
10. J.O. Schorge, S.C. Modesitt, R.L. Coleman, D.E. Cohn, N.D. Kauff, and L.R. Duska SGO White Paper on ovarian cancer: etiology, screening and surveillance Gynecol Oncol 119 1 2010 7 17
11. R.F. Ozols, S.C. Rubin, G.M. Thomas, and S.J. Robboy Epithelial ovarian cancer W.J. Hoskins, R.C. Young, M. Markman, C.A. Perez, R. Barakat, M. Randall, Principles and practices of gynecologic oncology 4th ed. 2005 Lippincott Williams & Wilkins New York 895 988
12. J. Boyd, and S.C. Rubin Hereditary ovarian cancer: molecular genetics and clinical implications Gynecol Oncol 64 2 1997 196 206
13. K. Kerlikowske, J.S. Brown, and D.G. Grady Should women with familial ovarian cancer undergo prophylactic oophorectomy? Obstet Gynecol 80 4 1992 700 707
14. J.M. Schildkraut, and W.D. Thompson Familial ovarian cancer: a population-based case-control study Am J Epidemiol 128 3 1988 456 466
15. A.S. Whittemore Characteristics relating to ovarian cancer risk: implications for prevention and detection Gynecol Oncol 55 3 Pt 2 1994 S15 19
16. A.S. Whittemore, G. Gong, and J. Itnyre Prevalence and contribution of BRCA1 mutations in breast cancer and ovarian cancer: results from three U.S. population-based case-control studies of ovarian cancer Am J Hum Genet 60 3 1997 496 504
17. F. Bray, A.H. Loos, S. Tognazzo, and C. La Vecchia Ovarian cancer in Europe: cross-sectional trends in incidence and mortality in 28 countries, 1953-2000 Int J Cancer 113 6 2005 977 990
18. SEER cancer statistics review 1975-2008 [ http://seer.cancer.gov/csr/ 1975-2008/, based on November 2010 SEER data submission, posted to the SEER web site, 2011.]
19. H.J. Kim, M.P. Fay, E.J. Feuer, and D.N. Midthune Permutation tests for joinpoint regression with applications to cancer rates Stat Med 19 3 2000 335 351
20. [ http://www.who.int/whosis ].
21. R.D. Cress, C.D. O'Malley, G.S. Leiserowitz, and S.L. Campleman Patterns of chemotherapy use for women with ovarian cancer: a population-based study J Clin Oncol 21 8 2003 1530 1535
22. L.C. Harlan, L.X. Clegg, and E.L. Trimble Trends in surgery and chemotherapy for women diagnosed with ovarian cancer in the United States J Clin Oncol 21 18 2003 3488 3494
23. M.M. Thrall, H.J. Gray, R.G. Symons, N.S. Weiss, D.R. Flum, and B.A. Goff Trends in treatment of advanced epithelial ovarian cancer in the Medicare population Gynecol Oncol 122 1 2011 100 106
24. A.S. Whittemore, M.L. Wu, R.S. Paffenbarger Jr., D.L. Sarles, J.B. Kampert, and S. Grosser Personal and environmental characteristics related to epithelial ovarian cancer. II. Exposures to talcum powder, tobacco, alcohol, and coffee Am J Epidemiol 128 6 1988 1228 1240
25. Ovarian cancer http://www.cancer.org/acs/groups/cid/documents/webcontent/ 003130-pdf.pdf
26. J.S. Berek, G.M. Thomas, and R.F. Ozols Ovarian cancer R.C. Bast, D.W. Kufe, R.E. Pollock, R.R. Weichselbaum, J.F. Holland, E. Frei, Holland-Frei cancer medicine 5th ed 2000
27. S.E. Hankinson, and K.N. Danforth Ovarian cancer D. Schottenfelt, J.F. Fraumeni Jr. Cancer epidemiology and prevention 3rd ed 2006 Oxford University Press 1013 1026
28. What you need to know about ovarian cancer http://www.cancer.gov/ cancertopics/wyntk/ovary/page4
29. R. Troisi, and P. Hartage Ovarian Cancer M.B. Goldman, M.C. Hatch, Women and health 2000 Academic Press San Diego, CA 907 915
30. F. Parazzini, S. Franceschi, C. La Vecchia, and M. Fasoli The epidemiology of ovarian cancer Gynecol Oncol 43 1 1991 9 23